Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: May 13, 2024
- Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP)
Read more at globenewswire.comNASDAQ:GBIO (7/30/2025, 2:45:31 PM)
4.3001
-0.11 (-2.49%)
Find more stocks in the Stock Screener
GBIO Latest News and Analysis
